dc.contributor.author |
Kurbonova Z.Ch., Sayfutdinova Z.A., Muhammadiev X.G., Xashimova G.T. |
|
dc.date.accessioned |
2022-12-13T05:56:05Z |
|
dc.date.available |
2022-12-13T05:56:05Z |
|
dc.date.issued |
2022 |
|
dc.identifier.uri |
http://repository.tma.uz/xmlui/handle/1/4914 |
|
dc.description.abstract |
This article provides an experimental justification for the use of hypoxia-inducible factor (HIF-1α) on the development and course of toxic hepatitis based on heliothrin intoxication. Acute heliothrin intoxication was reproduced by a single subcutaneous injection of a sublethal dose of heliothrin, prepared at the rate of 40 mg per 100 g of body weight, to rats. During the reproduction of experimental toxic hepatitis by the administration of heliothrin, it was found that the content of HIF-1 was on average equal to 0.101667±0.0022 ng/l. In blood plasma, mean HIF- 1 levels were 0.2136±0.0066 ng/1. |
en_US |
dc.language.iso |
en_US |
en_US |
dc.publisher |
Казахстан |
en_US |
dc.subject |
hypoxia-inducible factor; heliotrin intoxication; experimental toxic hepatitis; aryl hydrocarbon receptor transolator. |
en_US |
dc.title |
Experimental substantiation of the use of hypoxia-inducible factor (HIF-1α) for the development of toxic hepatitis |
en_US |
dc.type |
Article |
en_US |